GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » EV-to-Revenue

King International Investment (HKSE:00928) EV-to-Revenue : 0.60 (As of May. 11, 2024)


View and export this data going back to 2002. Start your Free Trial

What is King International Investment EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, King International Investment's enterprise value is HK$149.9 Mil. King International Investment's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was HK$250.9 Mil. Therefore, King International Investment's EV-to-Revenue for today is 0.60.

The historical rank and industry rank for King International Investment's EV-to-Revenue or its related term are showing as below:

HKSE:00928' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.36   Med: 3.53   Max: 713.56
Current: 0.6

During the past 13 years, the highest EV-to-Revenue of King International Investment was 713.56. The lowest was -1.36. And the median was 3.53.

HKSE:00928's EV-to-Revenue is ranked better than
88% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.24 vs HKSE:00928: 0.60

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), King International Investment's stock price is HK$0.078. King International Investment's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.16. Therefore, King International Investment's PS Ratio for today is 0.48.


King International Investment EV-to-Revenue Historical Data

The historical data trend for King International Investment's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment EV-to-Revenue Chart

King International Investment Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.39 -0.36 2.73 1.29 0.58

King International Investment Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.29 - 0.58 -

Competitive Comparison of King International Investment's EV-to-Revenue

For the Diagnostics & Research subindustry, King International Investment's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where King International Investment's EV-to-Revenue falls into.



King International Investment EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

King International Investment's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=149.887/250.873
=0.60

King International Investment's current Enterprise Value is HK$149.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. King International Investment's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was HK$250.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


King International Investment  (HKSE:00928) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

King International Investment's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.078/0.163
=0.48

King International Investment's share price for today is HK$0.078.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


King International Investment EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of King International Investment's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


King International Investment (HKSE:00928) Business Description

Traded in Other Exchanges
N/A
Address
18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG
King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines